Suppr超能文献

晚期晚发型庞贝病5年酶替代疗法的益处。一例误诊三十年、初诊时伴有急性呼吸衰竭的病例报告。

Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation.

作者信息

Maharaj Mandat, Skidmore David L, Croul Sidney E, Brake David J, Lochmuller Hanns

机构信息

Cape Breton Regional Hospital, Cape Breton, Nova Scotia, Dalhousie University, Canada.

IWK Hospital, Halifax, Nova Scotia, Dalhousie University, Canada.

出版信息

Mol Genet Metab Rep. 2022 Jul 18;32:100896. doi: 10.1016/j.ymgmr.2022.100896. eCollection 2022 Sep.

Abstract

We report on a 57 year old female patient who presented in acute respiratory failure with severe generalized weakness. She was previously misdiagnosed for over three decades as polymyositis. She was treated with enzyme replacement therapy (ERT) for over five years, after being diagnosed with late onset Pompe Disease (LOPD). She returned to independent living with the use of non invasive ventilation at nights. ERT should be considered in the management of patients with advanced LOPD and the effects of ERT closely monitored.

摘要

我们报告了一名57岁女性患者,她因严重的全身无力而出现急性呼吸衰竭。她此前被误诊为多肌炎长达三十多年。在被诊断为晚发型庞贝病(LOPD)后,她接受了五年多的酶替代疗法(ERT)。她通过夜间使用无创通气恢复了独立生活。对于晚期LOPD患者的管理应考虑ERT,并密切监测ERT的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a95/9421430/00ec4a5b83e6/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验